Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,204.50p
   
  • Change Today:
    -31.50p
  • 52 Week High: 1,435.00
  • 52 Week Low: 937.80
  • Currency: UK Pounds
  • Shares Issued: 849.76m
  • Volume: 352,539
  • Market Cap: £10,235m
  • RiskGrade: 173
  • Beta: 0.90

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.3% 0.0%
Div Cover 2.2 2.5
Op Mrgn 11.3% 17.9%
ROCE 13.3%  
Latest F'cast
P/E 19.6 16.2
PEG 10.8 n/a
Pr/Revenue 2.4 1.7
Pr/Book 2.7  
Latest F'cast
Revenue 4.7% -21.3%
PBT 71.7% 64.6%
EPS 1.8% -6.7%
DPS n/a -38.5%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 4,560.00 246.00 64.60¢ 31.4 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 21.4 0.9 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 18.2 18.2 +1% 37.50¢ 2.5%
31-Dec-23 5,549.00 290.00 82.80¢ 17.5 17.5 +1% 37.50¢ 2.6%
31-Dec-24 5,810.00 498.00 84.30¢ 15.8 7.9 +2% 37.50¢ 2.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 6,133.94 1,099.44 78.68p 15.7 n/a -7% 30.96p 0.0%
31-Dec-26 6,459.55 1,202.14 88.57p 14.0 1.1 +13% 34.24p 0.0%
31-Dec-27 6,799.08 1,318.75 92.61p 13.3 2.9 +5% 37.52p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Acquisition of Integrity Orthopaedics 12-Jan-2026 16:30 RNS
Total Voting Rights 02-Jan-2026 10:07 RNS
New Strategy and 2028 Financial Targets 08-Dec-2025 07:00 RNS

Smith and Nephew ShareCast News

RBC Capital cuts Smith & Nephew to 'sector perfo... 15-Dec-2025 ShareCast
Smith & Nephew boosts guidance as it unveils new... 08-Dec-2025 ShareCast
Director dealings: Smith & Nephew board members ... 07-Nov-2025 ShareCast

Smith and Nephew Top Newspaper Links

Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph
MARKET REPORT: Bid talk boosts Smith & Nephew 26-Nov-2014 Express & Star

Latest Smith and Nephew Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,204.50p
Change Today -31.50p
% Change -2.55 %
52 Week High 1,435.00
52 Week Low 937.80
Volume 352,539
Shares Issued 849.76m
Market Cap £10,235m
Beta 0.90
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.08% below the market average94.08% below the market average94.08% below the market average94.08% below the market average94.08% below the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
Price Trend
73.48% above the market average73.48% above the market average73.48% above the market average73.48% above the market average73.48% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average
Income
73.18% below the market average73.18% below the market average73.18% below the market average73.18% below the market average73.18% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
13.31% above the market average13.31% above the market average13.31% above the market average13.31% above the market average13.31% above the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 5
Buy 3
Neutral 8
Sell 1
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 02-Oct-25 27-Mar-25
Paid 07-Nov-25 28-May-25
Amount 15.00¢ 23.10¢

Trades for 19-Jan-2026

Time Volume / Share Price
13:40 710 @ 1,204.75p
13:35 836 @ 1,204.50p
13:35 542 @ 1,204.50p
13:35 40 @ 1,204.50p
13:35 165 @ 1,204.50p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page